$VTEX

Gomide de Faria Mariano sold $427K of VTEX (indirect holdings)

Gomide de Faria Mariano (Chief Executive Officer) sold 120,000 indirectly-held shares of VTEX (VTEX) at an average of $3.56 ($3.52–$3.58, $0.43M total) across 2 trades over 2026-08-17 to 2026-08-18.

Original reporting
SEC EDGAR · Gomide de Faria Mariano
Published Aug 19, 2026, 7:31 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 19, 2026, 7:32 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$VTEX
Bearish
medium confidence
Mentioned
$VTEX
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$VTEXBearishLow
01

Why it matters

The disclosed sale provides fresh data for traders assessing VTEX's short‑term price direction.

02

Market read

Primary relevance is to VTEX shareholders; limited broader market effect.

03

What to watch

Sale occurs without a 10b5‑1 plan, suggesting discretionary timing.

Relevance 4/10Novelty 4/10Timing: filed today

Background

SEC Form 4 filing discloses insider transactions for public companies.

Company-level read

Ticker impact

$VTEXBearishMedium confidence
Context

CEO Gomide de Faria Mariano sold 120,000 VTEX shares for $427K, reducing his stake to 913,929 shares.

Expected impact

Possible modest dip in VTEX price over the next few days.

Evidence & confidence

Sale size is modest relative to market cap, but CEO involvement adds weight.

Market effects

Limited impact on e‑commerce sector; only highlights typical insider activity.

No broader regional effect; confined to VTEX investors.

Minimal global relevance.

Counterpoint

Insider sale could be routine liquidity need, not a negative signal.

Key entities

  • Gomide de Faria Mariano

    Chief Executive Officer of VTEX

  • VTEX

    Brazilian e‑commerce platform listed on NYSE

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$VTEXMed

VTEX (VTEX) Just Turned A Profit Corner, But Growth Is Slowing

VTEX (NYSE:VTEX) reported Q2 2026 results showing improved profitability with non-GAAP income from operations up 62.4% YoY to $13.8M, and free cash flow up 79.1% to $12.7M. However, revenue growth slowed to 1.3% YoY on an FX-neutral basis, with management expecting flat growth for Q3. The company repurchased 6.2M shares for $23.2M during the quarter.

$VTEXMedAI 8/10

VTEX (VTEX) Q2 2026 Earnings Call Transcript

VTEX reported Q2 2026 results in an earnings call. GMV was $5.7B, up 7% FX-neutral. Subscription revenue was $63.8M, up 1.3% FX-neutral. Non-GAAP operating income rose 62% to $13.8M, with a 21.4% margin. Free cash flow was $12.7M, up 79%. Q3 guidance calls for flat FX-neutral subscription growth.

$VTEXMedAI 8/10

VTEX Q2 Earnings Call Highlights

VTEX (NYSE:VTEX) reported Q2 margin and cash flow improvement and guided for Q3 and full-year low-single-digit FX-neutral subscription revenue growth and low-20% non-GAAP operating and free cash flow margins. Q2 non-GAAP subscription gross margin rose to 81.8%. Free cash flow rose 79% to $12.7M. VTEX repurchased 6.2M shares at $3.76.

$VTEXMed

VTEX (VTEX): Financial results for Q2 2026

VTEX (VTEX) furnished an SEC Form 6-K — earnings release. VTEX Reports Second Quarter 2026 Financial Results Subscription revenue grew 11.4% (+1.3% FXN), with GMV up 17.8% (+7.0% FXN) Non-GAAP income from operations increased 62.4% to US$13.8 million, reaching a 21.4% margin Free cash flow increased 79.1% to US$12.7 million, reaching a